Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Masson

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
Toxicology|May 3, 2008
An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VXF Dorandeu, A Foquin, R Briot, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 30, 2011
Zonal shear and super-rotation in a magnetized spherical Couette-flow experimentD Brito, T Alboussière, P Cardin, et al.
Cell Reports|June 9, 2026
Cholera-toxin-induced disease generates epithelial-cell-derived L-lactate that promotes Vibrio cholerae growth in the small intestineMaria de la Paz Gutierrez, Jenna L Hall, Hugo L P Masson, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acidR Zamboni, M Belley, E Champion, et al.
Journal of Medicinal Chemistry|October 1, 1990
Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonistJ Y Gauthier, T Jones, E Champion, et al.
Bulletin of Experimental Biology and Medicine|August 31, 2017
Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate PoisoningS S Terekhov, V A Palikov, Y A Palikova, et al.
The Journal of Biological Chemistry|April 15, 1991
Use of the polymerase chain reaction for homology probing of butyrylcholinesterase from several vertebratesM Arpagaus, A Chatonnet, P Masson, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1991
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571T R Jones, R Zamboni, M Belley, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1995
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonistT R Jones, M Labelle, M Belley, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 1989
The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonistA W Ford-Hutchinson, Y Girard, A Lord, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Toxicology|May 3, 2008
An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VXF Dorandeu, A Foquin, R Briot, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 30, 2011
Zonal shear and super-rotation in a magnetized spherical Couette-flow experimentD Brito, T Alboussière, P Cardin, et al.
Cell Reports|June 9, 2026
Cholera-toxin-induced disease generates epithelial-cell-derived L-lactate that promotes Vibrio cholerae growth in the small intestineMaria de la Paz Gutierrez, Jenna L Hall, Hugo L P Masson, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acidR Zamboni, M Belley, E Champion, et al.
Journal of Medicinal Chemistry|October 1, 1990
Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonistJ Y Gauthier, T Jones, E Champion, et al.
Bulletin of Experimental Biology and Medicine|August 31, 2017
Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate PoisoningS S Terekhov, V A Palikov, Y A Palikova, et al.
The Journal of Biological Chemistry|April 15, 1991
Use of the polymerase chain reaction for homology probing of butyrylcholinesterase from several vertebratesM Arpagaus, A Chatonnet, P Masson, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1991
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571T R Jones, R Zamboni, M Belley, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1995
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonistT R Jones, M Labelle, M Belley, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 1989
The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonistA W Ford-Hutchinson, Y Girard, A Lord, et al.
Pageof 31